38
Participants
Start Date
September 30, 2008
Primary Completion Date
January 31, 2009
Study Completion Date
September 30, 2009
GCPGC, Neulasta, Placebo
A single subcutaneous administration of GCPGC 30 μg/kg, GCPGC 100 μg/kg, GCPGC 300 μg/kg, placebo or Neulasta 100 μg/kg
Clinical Trials Center, Seoul National University Hospital, Seoul
Collaborators (1)
Green Cross Corporation
INDUSTRY
Seoul National University Hospital
OTHER